Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (23)

2020

  1. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds (Nature Communications, (2019), 10, 1, (4731), 10.1038/s41467-019-12888-x)

    Nature Communications

2019

  1. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency

    Stem Cell Reports, Vol. 12, Núm. 5, pp. 1099-1112

  2. Identification and characterization of Cardiac Glycosides as senolytic compounds

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Adult Sox2+ stem cell exhaustion in mice results in cellular senescence and premature aging

    Aging Cell, Vol. 17, Núm. 5

  2. Pkd2 deletion during embryo development does not alter mesonephric programmed cell senescence

    International Journal of Developmental Biology, Vol. 62, Núm. 9-10, pp. 637-640

2016

  1. Analysis of the immune microenvironment in resected non-small cell lung cancer: The prognostic value of different T lymphocyte markers

    Oncotarget, Vol. 7, Núm. 33, pp. 52849-52861

2015

  1. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

    International Journal of Cancer, Vol. 137, Núm. 8, pp. 1870-1878

  2. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins

    Oncotarget, Vol. 6, Núm. 5, pp. 2992-3002

2014

  1. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer

    Endocrine-Related Cancer, Vol. 21, Núm. 4, pp. 587-599

2013

  1. Persistent polyclonal b-cell lymphocytosis with splenomegaly: Histologic description of 2 cases

    American Journal of Surgical Pathology, Vol. 37, Núm. 7, pp. 1085-1090

2011

  1. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 636-651

2010

  1. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

2009

  1. A TaqMan low-density array to predict outcome in advanced hodgkin's Lymphoma using paraffin-embedded samples

    Clinical Cancer Research, Vol. 15, Núm. 4, pp. 1367-1375

  2. Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma

    Journal of Neuropathology and Experimental Neurology, Vol. 68, Núm. 3, pp. 274-285

  3. Splenic follicular lymphoma: Clinicopathologic characteristics of a series of 32 cases

    American Journal of Surgical Pathology, Vol. 33, Núm. 5, pp. 730-738

2006

  1. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling

    Molecular Cancer, Vol. 5

  2. Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays

    Modern Pathology, Vol. 19, Núm. 5, pp. 684-694

2005

  1. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: A tissue microarray study

    Oncology Reports, Vol. 14, Núm. 6, pp. 1527-1531

  2. Large B-cell lymphoma with Hodgkin's features

    Histopathology, Vol. 47, Núm. 1, pp. 101-110

2004

  1. Building an Outcome Predictor Model for Diffuse Large B-Cell Lymphoma

    American Journal of Pathology, Vol. 164, Núm. 2, pp. 613-622